American Statistical Association
New York City
Metropolitan Area Chapter

Chapter Seminar
November 29, 2017

The New York Metro Area Chapter of the American Statistical Association

Is Pleased to Invite You to a Seminar On



Jeremy A. Rassen, M.S., Sc.D.
Co-Founder, President and Chief Scientific Officer at Aetion, Inc.


The presentation will discuss how the real-world data (RWD) available from the healthcare system, such as health insurance data and electronic medical records, can be used to characterize use of medical treatments and make decisions about the choices of medical treatments that best advance public health. It will present a short introduction to the sources of RWD and the use of RWD in research, and will present a framework for using RWD in a way that yields meaningful and valid results. It will also discuss cases where results from RWD-based studies can be used to supplement or take the place of randomized trials. The presentation will share examples of decision-making using a variety of "big data" sources, and will demonstrate both the concept and practice of quickly turning real-world data into quality evidence.

Speaker Biography

Jeremy A. Rassen, M.S., Sc.D. is a pharmacoepidemiologist with nearly 25 years of academic and industry experience. He is Co-Founder, President and Chief Scientific Officer at Aetion, Inc., a healthcare technology company that provides science-driven real-world evidence (RWE) solutions to healthcare companies, regulatory bodies and academic centers. Dr. Rassen leads Aetion's efforts to design, scale and communicate scientific methodologies for obtaining valid and timely medical evidence from real-world data. Prior to Aetion, Dr. Rassen was an assistant professor at Harvard Medical School, where he focused on methods for improving the quality and validity of studies based on real-world data, including administrative claims and electronic health records. In peer-reviewed publications and invited talks in the United States, Europe and Asia, he has looked at how real-world data can be used to validly, transparently and reproducibly measure the safety, effectiveness and value of medications and other treatments. Before coming to Harvard, Dr. Rassen worked in Silicon Valley in a variety technology companies, including Hewlett-Packard and Epiphany, Inc. His focus was on high-performance software for the creation and analysis of large databases. Dr. Rassen received his bachelor's degree in Computer Science from Harvard College and his masters and doctorate degrees in Epidemiology from the Harvard T.H. Chan School of Public Health.

Wednesday, November 29, 2017

5:00 P.M.
Doors open at 4:30 and talk begins at 5:00 P.M.
Please plan on arriving by 4:45 at the latest, to allow time to go through security.

Pfizer, Inc.
235 East 42nd Street
(between 2nd and 3rd Avenues)
2nd Floor, Room 3-D (next to the cafeteria)
New York, New York 10017

Go to 235 East 42nd Street (between 2nd and 3rd Avenues).
Be sure to have a photo ID.
You will be directed to the Security Reception area where your name will be listed for the meeting.
You will be provided with a badge that is required to go through the security gates.
When you enter through the security gates, please follow the signage to the meeting room.

Registration and Fees
Seating is limited.
Advanced registration is required and there is no fee.

Registration is now closed.
If you have any questions, please send an email to

Please bring a photo ID for security reasons.

Additional Information
For questions, send an e-mail to

The World of Statistics
Home Page | Chapter News | Chapter Officers | Chapter Events
Other Metro Area Events | ASA National Home Page | Links To Other Websites
NYC ASA Chapter Constitution | NYC ASA Chapter By-Laws

Page last modified on November 28, 2017

Copyright © 1998-2017 by New York City Metropolitan Area Chapter of the ASA
Designed and maintained by Cynthia Scherer
Send questions or comments to